Cynosure Receives CE Mark Approval for Affirm(TM) Laser System
September 07 2006 - 9:30AM
PR Newswire (US)
Micro-rejuvenation device designed to reduce the appearance of
wrinkles, scars and skin discoloration WESTFORD, Mass., Sept. 7
/PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading
developer and manufacturer of a broad array of light-based
aesthetic treatment systems, today announced it has received CE
mark approval for the Affirm(TM) system, the company's
single-platform, multi-energy technology for skin rejuvenation,
including treatments for wrinkles, skin texture and discoloration.
This approval allows for the marketing of the Affirm system
throughout the European Union, as well as many other countries
worldwide. "Gaining CE mark approval for the Affirm system -- our
fifth flagship product -- underscores the efficacy and reliability
of our award-winning technology," said Cynosure CEO Michael R.
Davin. "It also validates the success of our modular construction
and design, which provides greater flexibility to physician
practices by supporting a diverse range of high-volume skin
rejuvenation applications. "Skin rejuvenation represents one of the
fastest growing segments of the aesthetic laser marketplace," Davin
continued. "The initial market response to the Affirm system has
been decidedly positive, and we believe its ease of use,
versatility and speed will set it apart from competing devices. Our
proprietary disposable microlens array combined with the Affirm
system workstation offers providers the ability to treat patients
far more rapidly than other products available in the market today
-- thereby increasing patient throughput for doctors, treatment
centers or spas. We are enthusiastic about the long-term prospects
for the Affirm system." Cynosure remains on track to begin initial
Affirm system workstation shipments in the United States and Europe
in the third quarter of 2006. Pending the necessary regulatory
approvals, product shipments are expected to begin in Canada and
the Pacific Rim as early as the end of this year. "We have been
using the Affirm system for more than nine months and have achieved
outstanding results," said Robert A. Weiss, MD, of the Laser Skin
and Vein Institute in Baltimore. "Its speed and simplicity make
this an ideal technology for our practice. Our patients prefer it
to conventional energy delivery technologies for scar and wrinkle
treatments." The Affirm system is the only device utilizing the
Combined Apex Pulse(TM) (CAP) technology for reducing the
appearance of wrinkles and scars with micro-rejuvenation
capabilities to create a more complete skin treatment. The
proprietary CAP technology found in the Affirm system delivers
light energy of varying intensity levels to provide one platform
for the treatment for wrinkles, micro-rejuvenation and skin
discoloration. About Cynosure, Inc. Cynosure, Inc. develops and
markets aesthetic treatment systems that are used by physicians and
other practitioners to perform non-invasive procedures to remove
hair, treat vascular lesions, rejuvenate skin through the treatment
of shallow vascular and pigmented lesions and temporarily reduce
the appearance of cellulite. Cynosure's products include a broad
range of laser and other light-based energy sources, including
Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as
intense pulsed light. Cynosure was founded in 1991. For corporate
or product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosurelaser.com/. Any statements in this press release
about future expectations, plans and prospects for Cynosure, Inc.,
including statements about the future use and market acceptance of
the Affirm system, the markets in which Cynosure's products are
sold, and other statements containing the words "believes,"
"anticipates," "plans," "expects," "will," and similar expressions,
constitute forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including our
history of operating losses, our reliance on sole source suppliers,
competition in the aesthetic laser industry, economic, market,
technological and other factors discussed in Cynosure's Annual
Report on Form 10-K filed with the SEC. In addition, the
forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure
anticipates that subsequent events and developments will cause its
views to change. However, while Cynosure may elect to update these
forward-looking statements at some point in the future, it
specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing Cynosure's views as of any date subsequent to the date
of this press release. Contact: Scott Solomon Vice President Sharon
Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc.
CONTACT: Scott Solomon, Vice President of Sharon Merrill
Associates, Inc. for Cynosure, Inc., +1-617-542-5300, Web site:
http://www.cynosurelaser.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024